Ost-müük Bonus BioGroup Ltd. - BBIXF CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Kauplemistingimused
| Hinnavahe | - | ||||||||
|
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024068% | ||||||||
|
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.001846% | ||||||||
| Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
| Min kauplemise kogus | 1 | ||||||||
| Valuuta | USD | ||||||||
| Tagatis | 20% | ||||||||
| Aktsiabörs | United States of America | ||||||||
| Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Võtmestatistika
| Eelmine sulgemine* | N/A |
| Avatud* | N/A |
| Aastane muutus* | N/A |
| Päeva ulatus* | N/A |
| 52 nädala ulatus | 0.21-1.44 |
| Keskmine maht (10 päeva) | 2.51M |
| Keskmine maht (3 kuud) | 105.72M |
| Turukapitalisatsioon | 249.94M |
| P/E suhtarv | -100.00K |
| Ringluses olevad aktsiad | 1.17B |
| Tulu | N/A |
| EPS | -0.03 |
| Dividendid (% kasumist) | N/A |
| Beeta | 2.10 |
| Järgmine tuluaruande kuupäev | N/A |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
|---|
Bonus BioGroup Ltd. Events
| Kellaaeg (UTC) (UTC) | Riik | Sündmus |
|---|---|---|
| No events scheduled | ||
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Kogutulu | 0 | 0 | 0 | 0 | 0 |
| Tulu | 0 | 0 | |||
| Kogu tegevuskulu | 64.735 | 19.444 | 20.909 | 18.45 | 20.13 |
| Müük/Üldine/admin kulud, kokku | 43.75 | 8.023 | 9.752 | 7.567 | 9.201 |
| Uuringud ja arendus | 19.509 | 10.354 | 10.08 | 10.686 | 10.767 |
| Other Operating Expenses, Total | |||||
| Tulud majandustegevusest | -64.735 | -19.444 | -20.909 | -18.45 | -20.13 |
| Muud, neto | -24.936 | -1.408 | -0.195 | -0.364 | -0.067 |
| Netotulu enne makse | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
| Netotulu pärast makse | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
| Netotulu enne erikulusid | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
| Netotulu | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
| Arvestatav tulu, v a erikulud | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
| Arvestatav tulu, koos erikuludega | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
| Jaotamisele kuuluv netotulu | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
| Keskmine jaotamisele kuuluv aktsia kohta | 1154.06 | 998.981 | 841.467 | 811.497 | 808.995 |
| Jaotatav EPS, v a erakorralised kulud | -0.07805 | -0.02204 | -0.02643 | -0.02309 | -0.02497 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Jaotamisele kuuluv normaal-EPS | -0.07805 | -0.02204 | -0.02643 | -0.02309 | -0.02497 |
| Depreciation / Amortization | 1.476 | 1.067 | 1.077 | 0.197 | 0.162 |
| Intressitulud (kulu), muud tulud, neto | -0.405 | -1.169 | -1.136 | 0.079 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Kogutulu | 0 | 0 | 0 | 0 | 0 |
| Kogu tegevuskulu | 9.579 | 9.571 | 10.375 | 8.027 | 36.762 |
| Müük/Üldine/admin kulud, kokku | 3.645 | 4.117 | 3.635 | 4.643 | 31.548 |
| Uuringud ja arendus | 5.934 | 5.454 | 6.74 | 3.384 | 5.214 |
| Tulud majandustegevusest | -9.579 | -9.571 | -10.375 | -8.027 | -36.762 |
| Intressitulud (kulu), muud tulud, neto | 2.506 | -0.463 | -0.005 | 0 | 1.204 |
| Muud, neto | -0.231 | -5.973 | -1.148 | -9.556 | -9.4 |
| Netotulu enne makse | -7.304 | -16.007 | -11.528 | -17.583 | -44.958 |
| Netotulu pärast makse | -7.304 | -16.007 | -11.528 | -17.583 | -44.958 |
| Netotulu enne erikulusid | -7.304 | -16.007 | -11.528 | -17.583 | -44.958 |
| Netotulu | -7.304 | -16.007 | -11.528 | -17.583 | -44.958 |
| Arvestatav tulu, v a erikulud | -7.304 | -16.007 | -11.528 | -17.583 | -44.958 |
| Arvestatav tulu, koos erikuludega | -7.304 | -16.007 | -11.528 | -17.583 | -44.958 |
| Jaotamisele kuuluv netotulu | -7.304 | -16.007 | -11.528 | -17.583 | -44.958 |
| Keskmine jaotamisele kuuluv aktsia kohta | 1167.93 | 1155.96 | 1153.42 | 1069.13 | 1067.15 |
| Jaotatav EPS, v a erakorralised kulud | -0.00625 | -0.01385 | -0.00999 | -0.01645 | -0.04213 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Jaotamisele kuuluv normaal-EPS | -0.00625 | -0.01385 | -0.00999 | -0.01645 | -0.04213 |
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 81.001 | 16.737 | 0.308 | 9.088 | 4.651 |
| Raha ja lühiajalised investeeringud | 79.55 | 16.086 | 0.105 | 8.641 | 2.725 |
| Raha ja ekvivalendid | 79.55 | 16.086 | 0.105 | 8.641 | 2.725 |
| Laekumata arved, neto | 1.155 | 0.41 | 0.102 | 0.424 | 1.88 |
| Accounts Receivable - Trade, Net | |||||
| Other Current Assets, Total | |||||
| Total Assets | 104.322 | 51.437 | 6.99 | 10.158 | 5.577 |
| Property/Plant/Equipment, Total - Net | 14.961 | 5.726 | 6.585 | 0.973 | 0.824 |
| Intangibles, Net | 0.005 | ||||
| Other Long Term Assets, Total | 0.464 | 0.097 | 0.097 | 0.097 | 0.097 |
| Total Current Liabilities | 8.771 | 16.374 | 15.545 | 12.45 | 11.961 |
| Accounts Payable | 3.994 | 1.559 | 1.48 | 1.221 | 1.047 |
| Payable/Accrued | |||||
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 1.118 | 11.185 | 9.362 | 8.275 | 7.273 |
| Total Liabilities | 19.892 | 20.753 | 20.711 | 13.335 | 11.961 |
| Total Long Term Debt | 11.121 | 4.379 | 5.166 | 0 | 0 |
| Total Equity | 84.43 | 30.684 | -13.721 | -3.177 | -6.384 |
| Common Stock | 296.524 | 156.654 | 85.011 | 68.757 | 65.133 |
| Retained Earnings (Accumulated Deficit) | -212.094 | -125.97 | -105.346 | -87.731 | -71.517 |
| Other Equity, Total | 0 | 6.614 | 15.797 | 0 | |
| Total Liabilities & Shareholders’ Equity | 104.322 | 51.437 | 6.99 | 10.158 | 5.577 |
| Total Common Shares Outstanding | 1154.06 | 998.981 | 841.467 | 811.497 | 808.995 |
| Prepaid Expenses | 0.296 | 0.241 | 0.101 | 0.023 | 0.046 |
| Property/Plant/Equipment, Total - Gross | 20.455 | 9.762 | 9.575 | 2.886 | 2.538 |
| Accumulated Depreciation, Total | -5.494 | -4.036 | -2.99 | -1.913 | -1.714 |
| Accrued Expenses | 2.43 | 2.855 | 3.993 | 2.954 | 3.641 |
| Other Liabilities, Total | 0.885 | ||||
| Long Term Investments | 7.896 | 28.877 | 0 | ||
| Current Port. of LT Debt/Capital Leases | 1.229 | 0.775 | 0.71 | ||
| Capital Lease Obligations | 11.121 | 4.379 | 5.166 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 78.283 | 81.001 | 92.565 | 82.69 | 92.77 |
| Raha ja lühiajalised investeeringud | 71.95 | 79.55 | 91.467 | 81.257 | 88.778 |
| Raha ja ekvivalendid | 71.95 | 79.55 | 91.467 | 81.257 | 88.778 |
| Laekumata arved, neto | 6.333 | 1.451 | 1.098 | 1.433 | 3.992 |
| Accounts Receivable - Trade, Net | 6.333 | 1.451 | 1.098 | 1.433 | 3.992 |
| Total Assets | 105.758 | 104.322 | 117.112 | 96.567 | 118.308 |
| Property/Plant/Equipment, Total - Net | 18.518 | 14.961 | 12.649 | 1.752 | 5.87 |
| Long Term Investments | 8.493 | 7.896 | 11.434 | 11.661 | 19.571 |
| Other Long Term Assets, Total | 0.464 | 0.464 | 0.464 | 0.464 | 0.097 |
| Total Current Liabilities | 7.859 | 8.771 | 8.409 | 5.385 | 13.358 |
| Accounts Payable | 3.721 | 3.994 | 3.124 | 1.916 | 2.211 |
| Payable/Accrued | 2.869 | 2.494 | 2.972 | 2.119 | 5.231 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 1.243 | 1.229 | 1.477 | 0.31 | 0.798 |
| Other Current Liabilities, Total | 0.026 | 1.054 | 0.836 | 1.04 | 5.118 |
| Total Liabilities | 18.742 | 19.892 | 19.7 | 5.385 | 17.518 |
| Total Long Term Debt | 10.883 | 11.121 | 11.291 | 0 | 4.16 |
| Capital Lease Obligations | 10.883 | 11.121 | 11.291 | 0 | 4.16 |
| Total Equity | 87.016 | 84.43 | 97.412 | 91.182 | 100.79 |
| Common Stock | 307.606 | 296.524 | 295.909 | 241.537 | 204.652 |
| Retained Earnings (Accumulated Deficit) | -220.59 | -212.094 | -198.497 | -163.729 | -148.104 |
| Other Equity, Total | 0 | 0 | 13.374 | 44.242 | |
| Total Liabilities & Shareholders’ Equity | 105.758 | 104.322 | 117.112 | 96.567 | 118.308 |
| Total Common Shares Outstanding | 1167.93 | 1154.06 | 1153.42 | 1069.13 | 1067.15 |
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Netotulu/algväärtus | -90.076 | -22.021 | -22.24 | -18.735 | -20.197 |
| Raha majandustegevusest | -39.839 | -15.746 | -13.113 | -13.427 | -11.823 |
| Raha majandustegevusest | 1.476 | 1.067 | 1.077 | 0.197 | 0.163 |
| Mittelikviidsed varad | 57.174 | 4.89 | 5.673 | 3.143 | 7.76 |
| Muutused tööjõus | -8.413 | 0.318 | 2.377 | 1.968 | 0.451 |
| Tulu investeeringutelt | -6.176 | -0.254 | -0.187 | -0.341 | -0.269 |
| Kapitalikulutused | -5.809 | -0.254 | -0.187 | -0.341 | -0.269 |
| Muud rahavood investeeringutelt, kokku | -0.367 | 0 | 0 | ||
| Rahavood investeeringutelt | 113.418 | 31.921 | 4.918 | 19.559 | 13.416 |
| Rahavoogudesse investeerimine | 0 | 0 | 5.435 | 16.424 | 0 |
| Aktsiate emiteerimine (tagasiost), neto | 18.216 | 0.132 | 0.146 | 0.909 | 0.92 |
| Laenu väljastamine (kustutamine), neto | 95.202 | 31.789 | -0.663 | 2.226 | 12.496 |
| Rahaline kogumuutus | 63.464 | 15.981 | -8.536 | 5.916 | 1.324 |
| Muutused valuutakursside kõikumisest | -3.939 | 0.06 | -0.154 | 0.125 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -7.304 | -90.076 | -74.069 | -62.541 | -44.958 |
| Cash From Operating Activities | -8.254 | -39.839 | -33.442 | -28.644 | -19.798 |
| Cash From Operating Activities | 0.542 | 1.476 | 0.905 | 0.402 | 0.281 |
| Non-Cash Items | -0.171 | 57.174 | 48.25 | 44.179 | 32.52 |
| Changes in Working Capital | -1.321 | -8.413 | -8.528 | -10.684 | -7.641 |
| Cash From Investing Activities | -4.075 | -6.176 | -3.391 | -1.237 | -0.445 |
| Capital Expenditures | -4.075 | -5.809 | -3.024 | -0.87 | -0.445 |
| Cash From Financing Activities | 2.816 | 113.418 | 113.478 | 95.613 | 91.829 |
| Financing Cash Flow Items | 0 | 0 | 0 | 13.374 | 45.942 |
| Issuance (Retirement) of Stock, Net | 3.058 | 18.216 | 17.765 | 2.879 | 2.712 |
| Issuance (Retirement) of Debt, Net | -0.242 | 95.202 | 95.713 | 79.36 | 43.175 |
| Foreign Exchange Effects | 1.913 | -3.939 | -1.264 | -0.561 | 1.106 |
| Net Change in Cash | -7.6 | 63.464 | 75.381 | 65.171 | 72.692 |
| Other Investing Cash Flow Items, Total | 0 | -0.367 | -0.367 | -0.367 |
| Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
|---|---|---|---|---|---|---|
| Meretzki (Shai) | Individual Investor | 32.966 | 385017966 | 5551455 | 2022-12-28 | |
| Rauch (Yosef) | Individual Investor | 11.383 | 132945004 | 875000 | 2022-12-28 | |
| Shapira (Gil) | Individual Investor | 0.6085 | 7106418 | 0 | 2022-12-28 | |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1 | 1167456 | 19019 | 2023-02-28 | LOW |
| Reznick (Yehuda) | Individual Investor | 0.0626 | 730797 | 0 | 2022-12-28 |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
Kauplemise vahendustasu
0
- 1:1
Finantsvõimendus
1:1
- 20
- 100
- 500
- 1000
- 10000
Investeering
Tehingu suurus (võimendus x investeering):
Avamishind
Close
Lühike Pikk
Bonus BioGroup Ltd. Company profile
Ettevõttest Bonus BioGroup Ltd.
Bonus Biogroup Ltd, varem Oceana Advanced Industries Ltd, on Iisraelis asuv tootekeskne biotehnoloogiaettevõte, mis rakendab tehnoloogiat luuregenereerimise kudede tarnimiseks. Ettevõte arendab autoloogsetel ja allogeensetel luuimplantaatidel põhinevaid rakuteraapiatooteid, mis võimaldavad tõhusat luutransplantatsiooni ja pakuvad rakupõhist luuproteesimist luukahjustuste parandamiseks. Ettevõte on suunatud ülemaailmsele turule suurte haiguste, näiteks luu- ja kõhrega seotud artriidi, osteoporoosi ning mitmesuguste luude ja liigeste traumade, näiteks puusamurdude ja põlveliigese vigastuste raviks. 29. aprillil 2012 omandas Bonus Bio Group Ltd täielikult Bonus Therapeutic Ltd.
| Industry: | Bio Medical Devices |
פארק מת"מ 8ב'
HAIFA
3190501
IL
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com